The ClC-1 chloride channel inhibitor NMD670 improves skeletal muscle function in rat models and patients with myasthenia gravis.

Skov M, Ruijs TQ, Grønnebæk TS, Skals M, Riisager A, Winther JB, Dybdahl KLT, Findsen A, Morgen JJ, Huus N, Broch-Lips M, Nielsen OB, de Cuba CMKE, Heuberger JAAC, de Kam ML, Tannemaat M, Verschuuren JJGM, Knutsen LJS, Kelly NM, Jensen KG, Arnold WD, Burghes AH, Olesen C, Bold J, Petersen TK, Quiroz JA, Hutchison J, Chin ER, Groeneveld GJ, Pedersen TH

Open source

DOI: 10.1126/scitranslmed.adk9109
Published: 2024 Mar 20
Container: Science translational medicine
Publisher: Not recorded
Open access: no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1126/scitranslmed.adk9109,
  title = {The ClC-1 chloride channel inhibitor NMD670 improves skeletal muscle function in rat models and patients with myasthenia gravis.},
  author = {Skov M and Ruijs TQ and Grønnebæk TS and Skals M and Riisager A and Winther JB and Dybdahl KLT and Findsen A and Morgen JJ and Huus N and Broch-Lips M and Nielsen OB and de Cuba CMKE and Heuberger JAAC and de Kam ML and Tannemaat M and Verschuuren JJGM and Knutsen LJS and Kelly NM and Jensen KG and Arnold WD and Burghes AH and Olesen C and Bold J and Petersen TK and Quiroz JA and Hutchison J and Chin ER and Groeneveld GJ and Pedersen TH},
  year = {2024},
  journal = {Science translational medicine},
  doi = {10.1126/scitranslmed.adk9109},
  url = {https://doi.org/10.1126/scitranslmed.adk9109}
}

RIS

TY  - JOUR
TI  - The ClC-1 chloride channel inhibitor NMD670 improves skeletal muscle function in rat models and patients with myasthenia gravis.
AU  - Skov M
AU  - Ruijs TQ
AU  - Grønnebæk TS
AU  - Skals M
AU  - Riisager A
AU  - Winther JB
AU  - Dybdahl KLT
AU  - Findsen A
AU  - Morgen JJ
AU  - Huus N
AU  - Broch-Lips M
AU  - Nielsen OB
AU  - de Cuba CMKE
AU  - Heuberger JAAC
AU  - de Kam ML
AU  - Tannemaat M
AU  - Verschuuren JJGM
AU  - Knutsen LJS
AU  - Kelly NM
AU  - Jensen KG
AU  - Arnold WD
AU  - Burghes AH
AU  - Olesen C
AU  - Bold J
AU  - Petersen TK
AU  - Quiroz JA
AU  - Hutchison J
AU  - Chin ER
AU  - Groeneveld GJ
AU  - Pedersen TH
PY  - 2024
JO  - Science translational medicine
DO  - 10.1126/scitranslmed.adk9109
UR  - https://doi.org/10.1126/scitranslmed.adk9109
ER  -

APA

M, S., TQ, R., TS, G., M, S., A, R., JB, W., KLT, D., A, F., JJ, M., N, H., M, B., OB, N., CMKE, D. C., JAAC, H., ML, D. K., M, T., JJGM, V., LJS, K., NM, K., KG, J., WD, A., AH, B., C, O., J, B., TK, P., JA, Q., J, H., ER, C., GJ, G., & TH, P. (2024). The ClC-1 chloride channel inhibitor NMD670 improves skeletal muscle function in rat models and patients with myasthenia gravis.. Science translational medicine. https://doi.org/10.1126/scitranslmed.adk9109

Source records

pubmed · retrieved 2026-09-26T04:20:41.892Z
europe-pmc · retrieved 2026-09-26T04:20:41.910Z